Corbus Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -200 | -151 | ||
EBITDA | -9,396 | -13,250 | -9,145 | -9,471 |
EBIT | -9,530 | -13,402 | -9,345 | -9,622 |
Net Income | -9,530 | -13,783 | -9,997 | -6,898 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,942 | -13,942 | -8,942 | -7,967 |
Cash | 17,198 | 19,423 | 23,971 | 14,388 |
Basic Shares | 10,915 | 12,014 | 2,812 | 2,812 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $881 |
Gross Profit | -31,167 | -1,487 | -757 | |
EBITDA | -44,436 | -38,726 | -54,970 | |
EBIT | -45,077 | -40,214 | -56,609 | |
Net Income | -40,209 | -44,603 | -55,833 | -45,552 |
Net Change In Cash | 0 | 0 | 0 | 881 |
Free Cash Flow | -41,794 | -36,100 | -37,557 | -48,237 |
Cash | 17,198 | 13,723 | 17,002 | 25,006 |
Basic Shares | 10,915 | 4,327 | 4,170 | 4,099 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.78 |
2024-09-30 | -$1.15 |
2024-06-30 | -$0.90 |
2024-03-31 | -$0.83 |
